Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

ARNA 2.71 +0.06 (2.26%)
price chart
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sees Large Inflow of Net Money
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) dropped -2.81% or -0.08 points to trade at $2.64 per share. As per the latest trading data available, the net money flow stood at $0.39 million as the shares received $1.36 million in upticks and gave away $0 ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Price Target Update  News Watch International
Arena Pharmaceuticals, Inc. Short Interest Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stated gains of 512,286 shares or 1.8% in the short interest. The short interest registered from 27,821,423 on July 31,2015 to 28,333,709 on August 14,2015.
Arena Pharmaceuticals (ARNA) Rises: Stock Adds 5.7% in Session  Zacks.com
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Analyst Rating in Focus  Investor Newswire
Active Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), PepsiCo ...
Arena Solutions, declared that its flagship product, Arena PLM, now integrates with Kenandy Cloud ERP, an enterprise resource planning system for midmarket and large global enterprises built on the Salesforce Platform.
Disappointing 10-Q Numbers Push Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Down ...
The last few weeks have been shaping up as a real nightmare for investors tracking the chart performance of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA, ARNA message board). The reason: over the last three and a half weeks, ARNA shares have wiped a ...
Notable Session Mover: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Vanguard Tribune
Arena Pharmaceuticals Inc (NASDAQ:ARNA) near 52-week low , short interest down
Arena Pharmaceuticals Inc (NASDAQ:ARNA) (TREND ANALYSIS) shares were traded with a significant increase in volume. The stock closed last trading session at $3.02, down by -6.21%, with a volume of 4,443,906 shares against an average volume for the ...
3 Biotech Stocks Are Getting Crushed: Pharmaceuticals, Inc. (NASDAQ:ARNA ...  Wall Street Point
Healthcare Top Decliners: Omeros Corporation (NASDAQ:OMER), Arena ...  Stock Transcript
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Drops by -11.87%
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has lost 11.87% during the past week and dropped 26.67% in the last 4 weeks.
Short Interest Update on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), According to the latest information the short interest in Arena Pharmaceuticals, Inc. plummeted by 2.2% or 617,472 shares. The final shorts are 11.6% of the total floated shares. The positions dropped from ...
Stock in Focus - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Vanguard Tribune
Healthcare Sector Movers: Arena Pharmaceuticals, Inc. (ARNA), Relypsa, Inc ...  WallStreet Scope
Arena Pharmaceuticals Inc (NASDAQ:ARNA) Publicize Second Quarter Results
[PRNewswire] Arena Pharmaceuticals Inc (NASDAQ:ARNA)(TREND ANALYSIS) reported financial results for the second quarter ended June 30, 2015, and provided a corporate update.
Analyst Rating Update on Arena Pharmaceuticals, Inc.  News Watch International
Will Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Beat Analyst Estimates?  Markets Daily
Company Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Drops by -4.26%
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has lost 4.26% during the past week and dropped 25.11% in the last 4 weeks.
Arena Pharmaceuticals, Inc. Analyst Rating Update
Research firm Zacks has rated Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and has ranked it at 3, indicating that for the short term the shares are a hold.